Latest Insider Transactions at Dario Health Corp. (DRIO)
This section provides a real-time view of insider transactions for Dario Health Corp. (DRIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DarioHealth Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DarioHealth Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+9.09%
|
$0
$0.8 P/Share
|
|
Sep 10
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+10.0%
|
$0
$0.84 P/Share
|
|
Sep 09
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+11.11%
|
$0
$0.8 P/Share
|
|
Sep 06
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+12.5%
|
$0
$0.84 P/Share
|
|
Sep 05
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+14.29%
|
$0
$0.82 P/Share
|
|
Aug 27
2024
|
Erez Raphael Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.26%
|
$0
$0.88 P/Share
|
|
Aug 23
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+16.67%
|
$0
$0.95 P/Share
|
|
Aug 22
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+20.0%
|
$0
$0.94 P/Share
|
|
Aug 21
2024
|
Erez Raphael Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.26%
|
$0
$0.95 P/Share
|
|
Aug 21
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+25.0%
|
$0
$0.93 P/Share
|
|
Aug 20
2024
|
Erez Raphael Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.26%
|
$0
$0.93 P/Share
|
|
Aug 20
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+33.33%
|
$0
$0.94 P/Share
|
|
Aug 19
2024
|
Erez Raphael Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.26%
|
$0
$0.9 P/Share
|
|
Aug 19
2024
|
Steven Charles Nelson Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$0
$0.92 P/Share
|
|
Aug 16
2024
|
Erez Raphael Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.13%
|
$0
$0.9 P/Share
|
|
Mar 06
2024
|
Hila Karah Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+24.2%
|
-
|
|
Mar 06
2024
|
Jon H. Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+50.0%
|
-
|
|
Mar 06
2024
|
Yoav Shaked Director |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+26.0%
|
-
|
|
Mar 06
2024
|
Zvi Ben David Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+34.9%
|
-
|
|
Mar 06
2024
|
Adam K Stern Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+26.48%
|
-
|
|
Mar 06
2024
|
Dennis Matheis Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+31.44%
|
-
|
|
Mar 06
2024
|
Dennis M Mcgrath Director |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+34.08%
|
-
|
|
Mar 06
2024
|
Erez Raphael Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+29.5%
|
-
|
|
Jan 13
2023
|
Erez Raphael Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,200
-0.11%
|
$7,200
$6.21 P/Share
|
|
Dec 21
2022
|
Dennis M Mcgrath Director |
SELL
Open market or private sale
|
Direct |
9,872
-11.67%
|
$29,616
$3.97 P/Share
|
|
Jun 09
2022
|
Richard Allan Anderson President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,957
-14.16%
|
-
|
|
May 18
2022
|
Adam K Stern Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+30.67%
|
-
|
|
May 18
2022
|
Dennis M Mcgrath Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+39.39%
|
-
|
|
May 18
2022
|
Dror Bacher Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,000
+26.32%
|
-
|
|
May 18
2022
|
Erez Raphael Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
275,000
+19.81%
|
-
|
|
May 18
2022
|
Hila Karah Director |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+34.89%
|
-
|
|
May 18
2022
|
Zvi Ben David Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,000
+21.54%
|
-
|
|
May 18
2022
|
Yoav Shaked Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+26.53%
|
-
|
|
Nov 08
2021
|
Dror Bacher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
804
-0.47%
|
$15,276
$19.09 P/Share
|
|
Nov 08
2021
|
Erez Raphael Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
800
-0.1%
|
$15,200
$19.08 P/Share
|
|
Nov 05
2021
|
Erez Raphael Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
200
-0.02%
|
$3,800
$19.05 P/Share
|
|
Nov 05
2021
|
Dror Bacher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
200
-0.12%
|
$3,800
$19.06 P/Share
|
|
Nov 04
2021
|
Dror Bacher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
200
-0.12%
|
$3,800
$19.08 P/Share
|
|
Nov 04
2021
|
Erez Raphael Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,857
-0.93%
|
$141,426
$18.49 P/Share
|
|
Nov 03
2021
|
Erez Raphael Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,483
-3.47%
|
$548,694
$18.96 P/Share
|
|
Nov 03
2021
|
Dror Bacher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,016
-4.45%
|
$152,304
$19.13 P/Share
|
|
Nov 02
2021
|
Dror Bacher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,363
-2.36%
|
$82,897
$19.07 P/Share
|
|
Nov 02
2021
|
Erez Raphael Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
41,279
-4.49%
|
$743,022
$18.66 P/Share
|
|
Nov 01
2021
|
Erez Raphael Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,804
-2.73%
|
$464,472
$18.01 P/Share
|
|
Oct 14
2021
|
Oded Cohen GM MSK |
SELL
Open market or private sale
|
Direct |
20,000
-4.44%
|
$320,000
$16.11 P/Share
|
|
Oct 10
2021
|
Dror Bacher Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
357
+0.19%
|
-
|
|
Oct 10
2021
|
Erez Raphael Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
695
+0.07%
|
-
|
|
Oct 10
2021
|
Zvi Ben David Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
369
+0.15%
|
-
|
|
Jul 18
2021
|
Dror Bacher Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
353
+0.19%
|
-
|
|
Jul 18
2021
|
Erez Raphael Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
688
+0.07%
|
-
|